DN2 B cells, characterized by CD11c and T-bet expression, are enriched in IgG1-3-driven diseases like systemic lupus erythematosus (SLE), where they correlate with antibody levels and disease severity (7–10). The gene discussed is ITGAX; the disease is systemic lupus erythematosus.